Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/AMAL

AMAL

Series B
Geneva, SwitzerlandFounded 2012Nov 2018
Healthtech

AMAL raised €29M in a Series B round in Nov 2018. The company is based in Geneva, Switzerland. Investors in the round: Boehringer Ingelheim Venture Fund. Data as of Nov 2026.

← AMAL
Amount raised
€29M
€28,911,863
Native amount
33,000,000 CHF
Stage
Series B
series b
Investors
1

Provenance & confidence

High confidence
Amount
33,000,000 CHF
ECB-at-date → €29M · rate 1.1414 on 2018-11-09
High confidence
Source

startupticker.ch · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

1 named
Boehringer Ingelheim Venture Fund
Date
Nov 2018
Round type
series b
Amount (EUR)
€29M

Other rounds

same company

This is the company's only recorded round.

Related news